skip to content

Cambridge Public Health

 

I am a ARUK funded PhD student supervised by Prof Brayne exploring gender differences in dementia in the Cognitive Function in Ageing Study (CFAS). I am also a Specialty Registrar in Public Health in the East of England (out of programme).

Publications from Elements

Journal articles

2023

  • Liu, KY., Walsh, S., Brayne, C., Merrick, R., Richard, E. and Howard, R., 2023. Evaluation of clinical benefits of treatments for Alzheimer's disease. Lancet Healthy Longev, v. 4
    Doi: http://doi.org/10.1016/S2666-7568(23)00193-9
  • Wharton, SB., Simpson, JE., Ince, PG., Richardson, CD., Merrick, R., Matthews, FE., Brayne, C. and CFAS, , 2023. Insights into the pathological basis of dementia from population-based neuropathology studies. Neuropathol Appl Neurobiol, v. 49
    Doi: 10.1111/nan.12923
  • Merrick, R. and Matthews, FE., 2023. Time trends in neuropathology give clues to dementia risk reduction. Nat Rev Neurol, v. 19
    Doi: http://doi.org/10.1038/s41582-023-00812-3
  • Walsh, S., Merrick, R. and Brayne, C., 2023. Action needed on social and commercial determinants of neurological health - Authors' reply. Lancet Neurol, v. 22
    Doi: http://doi.org/10.1016/S1474-4422(23)00071-6
  • Nichols, E., Merrick, R., Hay, SI., Himali, D., Himali, JJ., Hunter, S., Keage, HAD., Latimer, CS., Scott, MR., Steinmetz, JD., Walker, JM., Wharton, SB., Wiedner, CD., Crane, PK., Keene, CD., Launer, LJ., Matthews, FE., Schneider, J., Seshadri, S., White, L., Brayne, C. and Vos, T., 2023. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia. Lancet Healthy Longev, v. 4
    Doi: http://doi.org/10.1016/S2666-7568(23)00019-3
  • Nelson, PT., Lee, EB., Cykowski, MD., Alafuzoff, I., Arfanakis, K., Attems, J., Brayne, C., Corrada, MM., Dugger, BN., Flanagan, ME., Ghetti, B., Grinberg, LT., Grossman, M., Grothe, MJ., Halliday, GM., Hasegawa, M., Hokkanen, SRK., Hunter, S., Jellinger, K., Kawas, CH., Keene, CD., Kouri, N., Kovacs, GG., Leverenz, JB., Latimer, CS., Mackenzie, IR., Mao, Q., McAleese, KE., Merrick, R., Montine, TJ., Murray, ME., Myllykangas, L., Nag, S., Neltner, JH., Newell, KL., Rissman, RA., Saito, Y., Sajjadi, SA., Schwetye, KE., Teich, AF., Thal, DR., Tomé, SO., Troncoso, JC., Wang, S-HJ., White, CL., Wisniewski, T., Yang, H-S., Schneider, JA., Dickson, DW. and Neumann, M., 2023. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol, v. 145
    Doi: http://doi.org/10.1007/s00401-022-02524-2
  • 2022 (Accepted for publication)

  • Walsh, S., Merrick, R., Richard, E., Nurrock, S. and Brayne, C., 2022 (Accepted for publication). Lecanemab for Alzheimer's disease BMJ: British Medical Journal,
    Doi: http://doi.org/10.1136/bmj.o3010
  • 2022

  • Nelson, PT., Brayne, C., Flanagan, ME., Abner, EL., Agrawal, S., Attems, J., Castellani, RJ., Corrada, MM., Cykowski, MD., Di, J., Dickson, DW., Dugger, BN., Ervin, JF., Fleming, J., Graff-Radford, J., Grinberg, LT., Hokkanen, SRK., Hunter, S., Kapasi, A., Kawas, CH., Keage, HAD., Keene, CD., Kero, M., Knopman, DS., Kouri, N., Kovacs, GG., Labuzan, SA., Larson, EB., Latimer, CS., Leite, REP., Matchett, BJ., Matthews, FE., Merrick, R., Montine, TJ., Murray, ME., Myllykangas, L., Nag, S., Nelson, RS., Neltner, JH., Nguyen, AT., Petersen, RC., Polvikoski, T., Reichard, RR., Rodriguez, RD., Suemoto, CK., Wang, S-HJ., Wharton, SB., White, L. and Schneider, JA., 2022. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol, v. 144
    Doi: http://doi.org/10.1007/s00401-022-02444-1
  • Rouanet, A., Avila-Rieger, J., Dugravot, A., Lespinasse, J., Stuckwisch, R., Merrick, R., Anderson, E., Long, L., Helmer, C., Jacqmin-Gadda, H., Dufouil, C., Judd, S., Manly, J., Sabia, S., Gross, A. and Proust-Lima, C., 2022. How Selection Over Time Contributes to the Inconsistency of the Association Between Sex/Gender and Cognitive Decline Across Cognitive Aging Cohorts. Am J Epidemiol, v. 191
    Doi: http://doi.org/10.1093/aje/kwab227
  • Walsh, S., Merrick, R. and Brayne, C., 2022. The relevance of social and commercial determinants for neurological health Lancet Neurology,
  • 2021

  • Walsh, S., Merrick, R., Milne, R. and Brayne, C., 2021. Aducanumab for Alzheimer's disease? BMJ, v. 374
    Doi: http://doi.org/10.1136/bmj.n1682
  • 2020

  • Merrick, R., Walsh, S., Ford, J., Morling, J. and Lee, ACK., 2020. Winter is coming, and it is going to be tough: COVID-19 and winter preparedness. Public Health,
    Doi: http://doi.org/10.1016/j.puhe.2020.07.037